Sector: Consumer Cyclicals | Industry: Tires & Rubber Products |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 725 Southbridge St WORCESTER MA 01610 |
Tel: | N/A |
Website: | https://www.vystarcorp.com |
IR: | See website |
Key People | ||
Jamie Rotman President, Director |
Business Overview |
Vystar Corporation uses patented technology to produce a line of air purifiers, which destroy viruses and bacteria through the use of ultraviolet light. It is also the creator and owner of Vytex Natural Rubber Latex (NRL) being used primarily in various bedding products. It uses patented ViraTech air purification technology, which destroys approximately 99% of bacteria and viruses and reduces concentrations of odors and volatile organic compounds (VOCs). The RxAir product line includes RxAir Residential Filterless Air Purifier, RX400 FDA cleared Class II Filterless Air Purifier and RX3000 Commercial FDA cleared Class II Air Purifier. The Company's RxAir product line uses 48 inches of high-intensity germicidal UV lamps that destroy bacteria, viruses and other germs instead of just trapping them, setting it apart from ordinary air filtration units. It sells RxAir residential and commercial units through multiple distributors and the Company's website. |
Financial Overview |
For the nine months ended 30 September 2023, Vystar Corp revenues increased from $206K to $506K. Net income before extraordinary items totaled $162K vs. loss of $1.8M. Revenues reflect Air purification unts segment increase from $26K to $460K, Mattresses and Toppers segment increase from $6K to $36K. Net Income reflects Gain/Loss on settlement of debt, net decrease from $2.3M (expense) to $0K. |
Employees: | 43 as of Dec 31, 2021 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $0.55M as of Sep 30, 2023 |
Annual revenue (TTM): | $0.42M as of Sep 30, 2023 |
EBITDA (TTM): | -$1.45M as of Sep 30, 2023 |
Net annual income (TTM): | -$1.14M as of Sep 30, 2023 |
Free cash flow (TTM): | -$0.28M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $0.48M as of Sep 30, 2023 |
Shares outstanding: | 12,942,592 as of Nov 14, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |